MedPath

Novel Biomarkers in Chronic Airway Diseases

Conditions
Asthma
COPD
Registration Number
NCT00849836
Lead Sponsor
Chonbuk National University
Brief Summary

The purpose of this study is:

* To define The differences of bio-chemical phenotypes in chronic airway inflammatory diseases.

* To identify novel biomarkers in chronic airway inflammatory diseases as a screening, diagnostic, or monitoring marker.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • > 18 years olds
  • Both sexes
  • Asthma or COPD was diagnosed according to the criteria of the American Thoracic Society, GINA, GOLD guideline
  • Acute exacerbation was defined by the criteria of the American Thoracic Society, GINA, GOLD guideline
  • For stable disease, none of the subjects had received inhaled or oral corticosteroids or any other anti-inflammatory drugs, had an exacerbation history in the previous 6 months
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chonbuk National University Medical School

🇰🇷

Jeonju, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath